search
Company Information
USD
1.76
- (-5.4%)
NASDAQ:CTMX, CYTOMX THERAPEUTICS, INC.
Industry: Biotechnology
End of Day: 17 April 2024 GMT-4
CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company which is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platform. The company probody technology platform to create proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Address

151 Oyster Point Boulevard
Suite 400

Classification

Sector

Healthcare

Industry Group

Biotechnology

Industry

Biotechnology

Key Executives

Mr. James R. Meyers
Director
Mr. Lloyd A. Rowland
Chief Compliance Officer/General Counsel/Secretary/Senior VP
Dr. Elaine V. Jones, PhD
Director
Ms. Halley E. Gilbert
Director
Mr. Matthew P. Young
Director
Dr. Sean A. McCarthy, D.Phil.
CEO/Chairman of the Board/Director
Dr. Mani Mohindru, PhD
Director
Dr. Alan Ashworth
Director
Mr. Christopher W. Ogden
CFO/Chief Accounting Officer/Senior VP, Divisional
Mr. Jeffrey B. Landau
Other Corporate Officer/Other Executive Officer/Senior VP

Ownership

Institution Holdings

Bvf Inc
6,595,801 (9.846%)
TANG CAPITAL MANAGEMENT LLC
6,450,000 (9.628%)
Vanguard Group Inc
4,902,943 (7.319%)
Tang Capital Partners LP
3,510,445 (5.258%)
Acadian Asset Management LLC
2,646,190 (3.950%)
Vanguard Investments Australia Ltd
2,182,220 (3.258%)
Renaissance Technologies Corp
1,325,700 (1.979%)
LAURION CAPITAL MANAGEMENT LP
1,188,225 (1.774%)
Fidelity Management & Research Company LLC
1,159,450 (1.731%)
BlackRock Inc
1,136,135 (1.696%)

Funds Holdings

Bridgeway Ultra Small Company Market Fd
188,500 (0.281%)
BlackRock Extended Equity Market
158,253 (0.236%)
Fidelity Enhanced Small Cap ETF
104,853 (0.157%)
Fidelity Series Total Market Index Fund
86,612 (0.129%)
NT Ext Equity Market Index Fund - L
66,151 (0.099%)
NT DJ US Complt Ttl Stk Mkt Idx Eq Strat
66,151 (0.099%)
NT Ext Equity Mkt Idx Fd - DC - NL
47,371 (0.071%)
BlackRock U.S. Equity Market
24,748 (0.037%)
Extended Equity Market Fund M
19,567 (0.029%)
SSgA U.S. Total Market Index Fund
6,057 (0.009%)

Details

Overview Company Info Key Ratios Income Balance Sheet Cash Flow
Make Smart Investment Choices